CS228917B2 - Method of preparing substituted derivatives of 1,4-dihydropyridine - Google Patents

Method of preparing substituted derivatives of 1,4-dihydropyridine Download PDF

Info

Publication number
CS228917B2
CS228917B2 CS821571A CS157182A CS228917B2 CS 228917 B2 CS228917 B2 CS 228917B2 CS 821571 A CS821571 A CS 821571A CS 157182 A CS157182 A CS 157182A CS 228917 B2 CS228917 B2 CS 228917B2
Authority
CS
Czechoslovakia
Prior art keywords
group
alkyl
formula
halogen
aryl
Prior art date
Application number
CS821571A
Other languages
Czech (cs)
English (en)
Inventor
Simon F Campbell
Peter E Cross
John K Stubbs
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to CS83125A priority Critical patent/CS228943B2/cs
Publication of CS228917B2 publication Critical patent/CS228917B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CS821571A 1981-03-14 1982-03-08 Method of preparing substituted derivatives of 1,4-dihydropyridine CS228917B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS83125A CS228943B2 (cs) 1981-03-14 1982-03-08 Způsob výroby substituovaných derivátů 1,4-dihydropyridinu

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8108088 1981-03-14

Publications (1)

Publication Number Publication Date
CS228917B2 true CS228917B2 (en) 1984-05-14

Family

ID=10520395

Family Applications (1)

Application Number Title Priority Date Filing Date
CS821571A CS228917B2 (en) 1981-03-14 1982-03-08 Method of preparing substituted derivatives of 1,4-dihydropyridine

Country Status (24)

Country Link
US (1) US4430333A (ko)
EP (1) EP0060674B1 (ko)
JP (1) JPS57206659A (ko)
KR (1) KR860001579B1 (ko)
AT (1) ATE15660T1 (ko)
AU (1) AU529854B2 (ko)
CA (1) CA1205480A (ko)
CS (1) CS228917B2 (ko)
DD (1) DD202430A5 (ko)
DE (1) DE3266272D1 (ko)
DK (1) DK155601C (ko)
ES (2) ES8305330A1 (ko)
FI (1) FI78470C (ko)
GR (1) GR75895B (ko)
HU (1) HU187657B (ko)
IE (1) IE52632B1 (ko)
IL (1) IL65222A (ko)
NO (1) NO159085C (ko)
NZ (1) NZ199990A (ko)
PH (1) PH17585A (ko)
PL (2) PL131190B1 (ko)
PT (1) PT74571B (ko)
YU (2) YU42461B (ko)
ZA (1) ZA821670B (ko)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
ATE50987T1 (de) * 1982-05-10 1990-03-15 Takeda Chemical Industries Ltd Dihydropyridinderivate, deren herstellung und verwendung.
DE3363743D1 (en) * 1982-07-22 1986-07-03 Pfizer Ltd Dihydropyridine anti-ischaemic and antihypertensive agents
HU192166B (en) * 1982-08-06 1987-05-28 Banyu Pharma Co Ltd Process for producing 2-carbamoyl-oxy-alkyl-1,4-dihydro-pyridine derivatives
PH19166A (en) * 1982-09-04 1986-01-16 Pfizer Dihydropyridined,pharmaceutical compositions and method of use
EP0107293A3 (en) * 1982-09-04 1984-06-06 Pfizer Limited Dihydropyridines
PL140069B1 (en) * 1982-12-21 1987-03-31 Pfizer Method of obtaining new derivatives of dihydropiridine
US4515799A (en) * 1983-02-02 1985-05-07 Pfizer Inc. Dihydropyridine anti-ischaemic and antihypertensive agents
GB8306666D0 (en) * 1983-03-10 1983-04-13 Pfizer Ltd Therapeutic agents
US4568677A (en) * 1983-07-23 1986-02-04 Pfizer Inc. 2-(4-Pyrimidone alkoxyalkyl) dihydropyridine anti-ischaemic and antihypertensive agents
US4603135A (en) * 1983-10-17 1986-07-29 Takeda Chemical Industries, Ltd. Substituted piperazinyl alkyl esters of 2-amino-4-aryl-1,4-dihydro-6-alkyl-3,5-pyridinedicarboxylates
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体
US5137889A (en) * 1983-12-02 1992-08-11 Otsuka Pharmaceutical Co., Ltd. Dihydropyridine derivatives and process for preparing the same
EP0168841B1 (en) * 1983-12-19 1988-09-28 Pfizer Limited Dihydropyridine intermediate
GB8401288D0 (en) * 1984-01-18 1984-02-22 Pfizer Ltd Therapeutic agents
US4895846A (en) * 1984-04-11 1990-01-23 Bristol-Myers Company Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters incorporating arylpiperazinylalkyl moieties
US4755512A (en) * 1984-04-11 1988-07-05 Bristol-Myers Company Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters incorporating arylpiperazinylalkyl moities
GB8412208D0 (en) * 1984-05-12 1984-06-20 Pfizer Ltd Quinolone inotropic agents
GB8414518D0 (en) * 1984-06-07 1984-07-11 Pfizer Ltd Therapeutic agents
GB8415386D0 (en) * 1984-06-15 1984-07-18 Pfizer Ltd Therapeutic agents
GR851819B (ko) * 1984-08-17 1985-11-26 Wyeth John & Brother Ltd
GB8421039D0 (en) * 1984-08-17 1984-09-19 Wyeth John & Brother Ltd Heterocyclic compounds
US4652573A (en) * 1985-03-14 1987-03-24 Nelson Research & Development Co. Calcium antagonist N-hetero ester 1,4-dihydropyridines
IT1204421B (it) * 1986-06-27 1989-03-01 Boehringer Biochemia Srl 2-(aminoalchiltio)metil-1,4-diidropiridine,un metodo per la loro preparazione e composizioni farmaceutiche che le contengono
EP0226271B1 (en) * 1985-08-21 1990-11-22 GLAXO S.p.A. 1,4-dihydropyridine compounds and their preparation and pharmaceutical formulation
NZ217282A (en) * 1985-08-21 1989-01-27 Glaxo Spa 1,4-dihydropyridine derivatives and pharmaceutical compositions
DE3531498A1 (de) * 1985-09-04 1987-03-05 Bayer Ag Dihydropyridin-2-hydroxyamine, verfahren zur herstellung und ihre verwendung in arzneimitteln
US4849436A (en) * 1986-03-11 1989-07-18 Nelson Research & Development Co. 1,4-dihydropyridines
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
FR2602231B1 (fr) * 1986-08-04 1988-10-28 Adir Nouveaux derives de la dihydro-1,4 pyridine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
WO1988001266A1 (en) * 1986-08-14 1988-02-25 Byk Gulden Lomberg Chemische Fabrik Gmbh New piperidines
IT1213555B (it) * 1986-12-11 1989-12-20 Boehringer Biochemia Srl 2 metiltiometildiidropiridine, un processo per laloro preparazione e composizioni farmaceutiche che le contengono.
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
JPH0688973B2 (ja) * 1987-03-12 1994-11-09 京都薬品工業株式会社 １，４−ジヒドロピリジン誘導体
GB8710493D0 (en) * 1987-05-02 1987-06-03 Pfizer Ltd Dihydropyridines
IT1205114B (it) * 1987-05-29 1989-03-15 Boehringer Biochemia Srl 2-selenometil-1,4-diidropiridine,procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
US4978533A (en) * 1988-11-01 1990-12-18 Pharmaconsult, Inc. Liquid nifidipine composition
US5635503A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Company Dihydropyridine npy antagonists: piperazine derivatives
ES2151850B1 (es) 1998-10-26 2001-08-16 Esteve Quimica Sa Intermedio para la sintesis de amlodipino para su obtencion y utilizacion correspondiente.
US6653481B2 (en) * 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
BR0116557A (pt) * 2000-12-29 2003-10-28 Pfizer Ltd Processo, processo para fabricação de um sal de maleato de amlodipina substancialmente livre de aspartato de amlodipina, processo para purificação, maleato de amlodipina, composição farmacêutica para tratar ou prevenir angina ou hipertenção, método para tratar hipertenção, angina ou ataque cardìaco, benzeno sulfonato de amlodipina, hidrocloreto de amlodipina e uso de maleato de amlodipina substancialmente livre de aspartato de amlodipina
US20040072879A1 (en) * 2002-10-10 2004-04-15 Dr. Reddy's Laboratories Limited Crystalline 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine maleate salt (Amlodipine)
WO2016155815A1 (en) 2015-04-01 2016-10-06 Ceva Sante Animale Oral solid dosage form of amlodipine and veterinary uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3946027A (en) 1972-09-30 1976-03-23 Bayer Aktiengesellschaft 3,5,6-Tricarboxy-4-pyridyl-1,4-dihydropyridine derivatives
US3946028A (en) 1972-09-30 1976-03-23 Bayer Aktiengesellschaft 2,3,5,6-Tetracarboxy-4-pyridyl-1,4-dihydropyridine derivatives
US3943140A (en) 1972-09-30 1976-03-09 Bayer Aktiengesellschaft 2,3,5,6-Tetracarboxy-1,4-dihydropyridine derivatives
DE2248150A1 (de) 1972-09-30 1974-04-04 Bayer Ag Dihydropyridinpolyester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
BE843576A (fr) 1975-04-03 1976-12-29 Derives de 1,4-dihydropyridine et leur procede de preparation
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
DE2658183A1 (de) 1976-12-22 1978-07-06 Bayer Ag In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2715182A1 (de) 1977-04-05 1978-10-19 Bayer Ag 2-alkylenaminodihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4177278A (en) 1977-04-05 1979-12-04 Bayer Aktiengesellschaft 2-Alkyleneaminodihydropyridines compounds, their production and their medicinal use
US4307103A (en) 1978-09-08 1981-12-22 Fujisawa Pharmaceutical Co., Ltd. Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same

Also Published As

Publication number Publication date
KR860001579B1 (ko) 1986-10-10
FI78470B (fi) 1989-04-28
DK109982A (da) 1982-09-15
CA1205480A (en) 1986-06-03
ES8402273A1 (es) 1984-01-16
NZ199990A (en) 1984-07-06
FI78470C (fi) 1989-08-10
DK155601B (da) 1989-04-24
JPS57206659A (en) 1982-12-18
PH17585A (en) 1984-10-02
EP0060674B1 (en) 1985-09-18
YU55082A (en) 1984-12-31
HU187657B (en) 1986-02-28
ES510402A0 (es) 1983-04-01
AU529854B2 (en) 1983-06-23
DD202430A5 (de) 1983-09-14
DE3266272D1 (en) 1985-10-24
ES518489A0 (es) 1984-01-16
ATE15660T1 (de) 1985-10-15
ZA821670B (en) 1983-01-26
PT74571A (en) 1982-04-01
IE52632B1 (en) 1988-01-06
AU8136482A (en) 1982-11-04
NO159085C (no) 1988-11-30
IL65222A0 (en) 1982-05-31
PL132199B1 (en) 1985-02-28
DK155601C (da) 1989-09-11
NO159085B (no) 1988-08-22
YU42461B (en) 1988-08-31
YU42902B (en) 1988-12-31
EP0060674A1 (en) 1982-09-22
FI820840L (fi) 1982-09-15
PT74571B (en) 1984-11-27
NO820825L (no) 1982-09-15
IL65222A (en) 1985-08-30
PL131190B1 (en) 1984-10-31
PL235363A1 (en) 1983-03-14
GR75895B (ko) 1984-08-02
IE820572L (en) 1982-09-14
YU155884A (en) 1985-03-20
ES8305330A1 (es) 1983-04-01
US4430333A (en) 1984-02-07
JPS6155907B2 (ko) 1986-11-29
PL238960A1 (en) 1983-07-18
KR830009025A (ko) 1983-12-17

Similar Documents

Publication Publication Date Title
CS228917B2 (en) Method of preparing substituted derivatives of 1,4-dihydropyridine
KR100543614B1 (ko) 4-페닐피페리딘 화합물
KR870000809B1 (ko) 1,4-디하이드로피리딘의 제조방법
US4374841A (en) Pyridoxine derivatives, and use in therapeutics
JP3238397B2 (ja) 新規のスルホニル化合物
PL140573B1 (en) Method of obtaining new dihydropyridine derivatives
DK156392B (da) Analogifremgangsmaade til fremstilling af aminopropoxyindolderivater
JPS6222985B2 (ko)
JPH01294675A (ja) １，４−ジヒドロピリジン誘導体、これらの製造法およびこれらの薬剤としての適用
US4652573A (en) Calcium antagonist N-hetero ester 1,4-dihydropyridines
US5328931A (en) N-alkylated 1,4-dihydropyridinedicarboxylic acid esters
US4505920A (en) Certain N-substituted-4-aryl-3,5-pyridine dicarboxylates and their antihypertensive use
US4677108A (en) 4-oxo-pyrido[2,3-d]pyrimidinone derivatives
US4547502A (en) Dihydropyridines and their use in treating cardiac conditions and hypertension
JPH02124885A (ja) イミダゾール抗不整脈剤
US4500532A (en) 1-(Substituted aminoalkyl)-1,4-dihydropyridines
KR100355973B1 (ko) 페닐-치환1,4-디히드로피리딘
JP4163260B2 (ja) １，４−ジヒドロピリジン誘導体および治療におけるその使用
US4833150A (en) 1,4-dihydropyridines
EP0216542B1 (en) Dihydropyridine derivatives
IE66677B1 (en) New Diaryl Compounds
JPS63280062A (ja) ジヒドロピリジン化合物および該化合物を含む薬剤組成物
JP2000508297A (ja) 抗高血圧活性を有する新規キナゾリン―４―アミノ―２―（ピペリジン―１―イル―４―置換）誘導体並びにその製造法および医薬用途
CS228943B2 (cs) Způsob výroby substituovaných derivátů 1,4-dihydropyridinu
JPS62252769A (ja) 複素環誘導体